From the administrators' statement

The Company was incorporated 28 September 2020 by Messrs Mark Kotter, Daniel Ives and Florian Schuster.

The Company's principal activity was research and experimental development in biotechnology. From its inception, the Company operated as an early-stage life sciences business focused on scientific research and innovation rather than revenue generation.

The Company was established to develop proprietary scientific platforms aimed at understanding and reversing cellular ageing, utilising stem-cell technology and functional genomics. Its activities were primarily research-driven and required ongoing expenditure on skilled personnel and laboratory facilities. As is typical for companies operating in this sector, the Company had limited or no trading income during its development phase and was dependent on external funding to support its operations and research programme.

Dig into any UK company's accounts

Search a company to fetch every set of accounts it has filed at Companies House, from incorporation to the latest filing. Tagged (iXBRL) accounts are read directly. Older scanned PDF accounts are read with OCR (optical character recognition).

Profit & loss: revenue, margins and profit, year by year
Balance sheet: assets, liabilities, working capital and net assets
Cash flow: operating, investing and financing flows and free cash flow
Groups: consolidated figures are used when a group files group accounts

Processing now

Clock BIO Limited (12909273)

Export CSV